
Agilent Technologies Inc (A) - Product Pipeline Analysis, 2024 Update
Description
Agilent Technologies Inc (A) - Product Pipeline Analysis, 2024 Update
Summary
Agilent Technologies Inc (Agilent) is a provider of analyzing instruments, reagents, and consumables for laboratory processes. It also offers allied software and services. The company is primarily focused on scientific research, patient diagnostics, and safety testing for water, food, and pharmaceuticals. Its product portfolio includes mass spectrometry, microarray solutions, flow cytometry, vacuum technologies and others. Agilent caters to varied industries, including contract research organizations (CROs), contract manufacturing organizations (CMOs), pharmaceuticals, diagnostics, applied materials, and chemicals. The company has a significant presence across the world, with sales offices, logistics centers, R&D centers and business facilities. It commercializes its products through a network of direct sales agents, distributors, resellers, manufacturers' representatives and electronic commerce. Agilent is headquartered in Santa Clara, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Agilent Technologies Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
67 Pages
- Agilent Technologies Inc Company Overview
- Agilent Technologies Inc Company Snapshot
- Agilent Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview
- Agilent Technologies Inc – Pipeline Analysis Overview
- Business Description
- Agilent Technologies Inc - Key Facts
- Agilent Technologies Inc - Major Products and Services
- Agilent Technologies Inc Pipeline Products by Development Stage
- Agilent Technologies Inc Pipeline Products Overview
- Agilent Dako SARS-CoV-2 IgG ELISA Kit
- Agilent Dako SARS-CoV-2 IgG ELISA Kit Product Overview
- Amgen Companion Diagnostic Test - Gastroesophageal Cancer
- Amgen Companion Diagnostic Test - Gastroesophageal Cancer Product Overview
- Bioenergetic Health Index Test
- Bioenergetic Health Index Test Product Overview
- Companion Diagnostic Assay - Cancer
- Companion Diagnostic Assay - Cancer Product Overview
- Companion Diagnostic PD-L1 Test
- Companion Diagnostic PD-L1 Test Product Overview
- Companion Diagnostic Test - IQFISH Hybridization
- Companion Diagnostic Test - IQFISH Hybridization Product Overview
- Companion Diagnostic Test - Pemigatinib
- Companion Diagnostic Test - Pemigatinib Product Overview
- Companion Diagnostic Test - INCA32459
- Companion Diagnostic Test - INCA32459 Product Overview
- Companion Diagnostic Test - INCA33890
- Companion Diagnostic Test - INCA33890 Product Overview
- Companion Diagnostic Test - INCAGN2385
- Companion Diagnostic Test - INCAGN2385 Product Overview
- Companion Diagnostic Test - INCAGN2390
- Companion Diagnostic Test - INCAGN2390 Product Overview
- Companion Diagnostic Test - INCB123667
- Companion Diagnostic Test - INCB123667 Product Overview
- Companion Diagnostic Test - INCB161734
- Companion Diagnostic Test - INCB161734 Product Overview
- Companion Diagnostic Test - INCB99280
- Companion Diagnostic Test - INCB99280 Product Overview
- Companion Diagnostic Test - INCB99318
- Companion Diagnostic Test - INCB99318 Product Overview
- Companion Diagnostic Test - Itacitinib
- Companion Diagnostic Test - Itacitinib Product Overview
- Companion Diagnostic Test - Retifanlimab
- Companion Diagnostic Test - Retifanlimab Product Overview
- Companion Diagnostic Test - Tafasitamab
- Companion Diagnostic Test - Tafasitamab Product Overview
- Diagnostic Test - Neurological Diseases
- Diagnostic Test - Neurological Diseases Product Overview
- Electron Capture Dissociation Based Diagnostic Tool
- Electron Capture Dissociation Based Diagnostic Tool Product Overview
- MET4 PharmDx Companion Diagnostic Assay - Cancer
- MET4 PharmDx Companion Diagnostic Assay - Cancer Product Overview
- Next Generation Sequencing System - Pathogen Identification
- Next Generation Sequencing System - Pathogen Identification Product Overview
- Resolution CtDx FIRST Assay
- Resolution HRD Assay
- Resolution HRD Assay Product Overview
- VeriTag C. Difficile Drug Resistance Diagnostic Test
- VeriTag C. Difficile Drug Resistance Diagnostic Test Product Overview
- VeriTag Drug Resistance Diagnostic Test - Influenza
- VeriTag Drug Resistance Diagnostic Test - Influenza Product Overview
- VeriTag Drug Resistance Diagnostic Test - MRSA
- VeriTag Drug Resistance Diagnostic Test - MRSA Product Overview
- VeriTag HBV Drug Resistance Diagnostic Test
- VeriTag HBV Drug Resistance Diagnostic Test Product Overview
- VeX-HCV Assay
- VeX-HCV Assay Product Overview
- VeX-HIV Assay
- VeX-HIV Assay Product Overview
- Agilent Technologies Inc - Key Competitors
- Agilent Technologies Inc - Key Employees
- Agilent Technologies Inc - Key Employee Biographies
- Agilent Technologies Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Agilent Technologies Inc, Recent Developments
- May 22, 2024: Agilent at ASMS 2024: Driving Scientific Breakthroughs with Unparalleled Mass Spec Solutions
- Apr 15, 2024: Agilent Receives European IVDR Class C Certification for GenetiSure Dx Postnatal Assay
- Feb 21, 2024: Agilent CEO Mike McMullen to Retire; Agilent CrossLab Group President Padraig McDonnell Named CEO-Elect
- Jan 16, 2024: Agilent Announces New ProteoAnalyzer System
- Jan 16, 2024: MSD Highlights Biomarker Testing To Deliver Gastric Cancer Immunotherapy
- Nov 14, 2023: Agilent Receives FDA Approval for PD-L1 IHC 22C3 Pharmdx in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
- Nov 07, 2023: FDA Amends Pembrolizumab’s Gastric Cancer Indication
- Oct 06, 2023: Agilent and Sarawak Infectious Disease Centre Partner to Boost Neglected Tropical Diseases Research in East Malaysia
- Sep 19, 2023: Agilent and NCCS Sign Research Collaboration Agreement to Advance Singapore’s Genomic Profiling on Asian-prevalent Cancers
- Aug 24, 2023: Agilent Receives European IVDR Certification For Companion Diagnostic Assay
- Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Table 1: Agilent Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview
- Table 2: Agilent Technologies Inc Pipeline Products by Equipment Type
- Table 3: Agilent Technologies Inc Pipeline Products by Indication
- Table 4: Agilent Technologies Inc, Key Facts
- Table 5: Agilent Technologies Inc, Major Products and Services
- Table 6: Agilent Technologies Inc Number of Pipeline Products by Development Stage
- Table 7: Agilent Technologies Inc Pipeline Products Summary by Development Stage
- Table 8: Agilent Dako SARS-CoV-2 IgG ELISA Kit - Product Status
- Table 9: Agilent Dako SARS-CoV-2 IgG ELISA Kit - Product Description
- Table 10: Amgen Companion Diagnostic Test - Gastroesophageal Cancer - Product Status
- Table 11: Amgen Companion Diagnostic Test - Gastroesophageal Cancer - Product Description
- Table 12: Bioenergetic Health Index Test - Product Status
- Table 13: Bioenergetic Health Index Test - Product Description
- Table 14: Companion Diagnostic Assay - Cancer - Product Status
- Table 15: Companion Diagnostic Assay - Cancer - Product Description
- Table 16: Companion Diagnostic PD-L1 Test - Product Status
- Table 17: Companion Diagnostic PD-L1 Test - Product Description
- Table 18: Companion Diagnostic Test - IQFISH Hybridization - Product Status
- Table 19: Companion Diagnostic Test - IQFISH Hybridization - Product Description
- Table 20: Companion Diagnostic Test - Pemigatinib - Product Status
- Table 21: Companion Diagnostic Test - Pemigatinib - Product Description
- Table 22: Companion Diagnostic Test - INCA32459 - Product Status
- Table 23: Companion Diagnostic Test - INCA32459 - Product Description
- Table 24: Companion Diagnostic Test - INCA33890 - Product Status
- Table 25: Companion Diagnostic Test - INCA33890 - Product Description
- Table 26: Companion Diagnostic Test - INCAGN2385 - Product Status
- Table 27: Companion Diagnostic Test - INCAGN2385 - Product Description
- Table 28: Companion Diagnostic Test - INCAGN2390 - Product Status
- Table 29: Companion Diagnostic Test - INCAGN2390 - Product Description
- Table 30: Companion Diagnostic Test - INCB123667 - Product Status
- Table 31: Companion Diagnostic Test - INCB123667 - Product Description
- Table 32: Companion Diagnostic Test - INCB161734 - Product Status
- Table 33: Companion Diagnostic Test - INCB161734 - Product Description
- Table 34: Companion Diagnostic Test - INCB99280 - Product Status
- Table 35: Companion Diagnostic Test - INCB99280 - Product Description
- Table 36: Companion Diagnostic Test - INCB99318 - Product Status
- Table 37: Companion Diagnostic Test - INCB99318 - Product Description
- Table 38: Companion Diagnostic Test - Itacitinib - Product Status
- Table 39: Companion Diagnostic Test - Itacitinib - Product Description
- Table 40: Companion Diagnostic Test - Retifanlimab - Product Status
- Table 41: Companion Diagnostic Test - Retifanlimab - Product Description
- Table 42: Companion Diagnostic Test - Tafasitamab - Product Status
- Table 43: Companion Diagnostic Test - Tafasitamab - Product Description
- Table 44: Diagnostic Test - Neurological Diseases - Product Status
- Table 45: Diagnostic Test - Neurological Diseases - Product Description
- Table 46: Electron Capture Dissociation Based Diagnostic Tool - Product Status
- Table 47: Electron Capture Dissociation Based Diagnostic Tool - Product Description
- Table 48: MET4 PharmDx Companion Diagnostic Assay - Cancer - Product Status
- Table 49: MET4 PharmDx Companion Diagnostic Assay - Cancer - Product Description
- Table 50: Next Generation Sequencing System - Pathogen Identification - Product Status
- Table 51: Next Generation Sequencing System - Pathogen Identification - Product Description
- Table 52: Resolution CtDx FIRST Assay - Product Description
- Table 53: Resolution HRD Assay - Product Status
- Table 54: Resolution HRD Assay - Product Description
- Table 55: VeriTag C. Difficile Drug Resistance Diagnostic Test - Product Status
- Table 56: VeriTag C. Difficile Drug Resistance Diagnostic Test - Product Description
- Table 57: VeriTag Drug Resistance Diagnostic Test - Influenza - Product Status
- Table 58: VeriTag Drug Resistance Diagnostic Test - Influenza - Product Description
- Table 59: VeriTag Drug Resistance Diagnostic Test - MRSA - Product Status
- Table 60: VeriTag Drug Resistance Diagnostic Test - MRSA - Product Description
- Table 61: VeriTag HBV Drug Resistance Diagnostic Test - Product Status
- Table 62: VeriTag HBV Drug Resistance Diagnostic Test - Product Description
- Table 63: VeX-HCV Assay - Product Status
- Table 64: VeX-HCV Assay - Product Description
- Table 65: VeX-HIV Assay - Product Status
- Table 66: VeX-HIV Assay - Product Description
- Table 67: Agilent Technologies Inc, Key Employees
- Table 68: Agilent Technologies Inc, Key Employee Biographies
- Table 69: Agilent Technologies Inc, Subsidiaries
- Table 70: Glossary
- List of Figures
- Figure 1: Agilent Technologies Inc Pipeline Products by Equipment Type
- Figure 2: Agilent Technologies Inc Pipeline Products by Development Stage
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.